Polymorphic variants in exon 8 at the 3' UTR of the HLA-G gene are associated with septic shock in critically ill patients

Critical Care

Volumn 16, Issue 5, 2012, Pages

  Graebin, Pietra ^a   Veit, Tiago D ^a   Alho, Clarice S ^a   Dias, Fernando S ^b   Chies, José A B ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

HLA G ANTIGEN; ISOPROTEIN; 3' UNTRANSLATED REGION;

3' UNTRANSLATED REGION; ADOLESCENT; ADULT; AGED; ALTERNATIVE RNA SPLICING; ANTIGEN EXPRESSION; ARTICLE; CRITICALLY ILL PATIENT; DATA ANALYSIS SOFTWARE; DNA POLYMORPHISM; EXON; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; HAPLOTYPE; HEREDITY; HETEROZYGOSITY; HUMAN; HUMAN TISSUE; IMMUNOMODULATION; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PREDICTIVE VALIDITY; PRIORITY JOURNAL; SEPTIC SHOCK; BRAZIL; CRITICAL ILLNESS; EPIDEMIOLOGY; GENETICS; GENOTYPE; INTENSIVE CARE UNIT; MIDDLE AGED; MORTALITY; SINGLE NUCLEOTIDE POLYMORPHISM;

3' UNTRANSLATED REGIONS; BRAZIL; CRITICAL ILLNESS; EXONS; FEMALE; GENE FREQUENCY; GENOTYPE; HAPLOTYPES; HLA-G ANTIGENS; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; SHOCK, SEPTIC;

EID: 84867901079     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc11845     Document Type: Article

References (69)

1. Vincent JL. Sepsis: The magnitude of the problem. The Sepsis Text 2002 2002, Kluwer Academic Publisher, Dordrecht, the Netherlands.
2. Latin American Sepsis Institute. , http://www.sepsisnet.org
3. Holmes CL. Genetic Polymorphisms in Sepsis and Septic Shock: Role in Prognosis and Potential for Therapy. Chest 2003, 124:1103-1115. 10.1378/chest.124.3.1103, 12970043.
4. Donadi EA, Castelli EC, Arnaiz-Villena A, Roger M, Rey D, Moreau P. Implications of the polymorphism of HLA-G on its function, regulation, evolution and disease association. Cell Mol Life Sci 2011, 68:369-395. 10.1007/s00018-010-0580-7, 3021195, 21107637.
5. Carosella ED, Dausset J, Rouas-Freiss N. Immunotolerant functions of HLA-G. Cell Mol Life Sci 1999, 55:327-333. 10.1007/s000180050295, 10228553.
6. Gonen-Gross T, Goldman-Wohl D, Huppertz B, Lankry D, Greenfield C, Natanson-Yaron S, Hamani Y, Gilad R, Yagel S, Mandelboim O. Inhibitory NK receptor recognition of HLA-G: regulation by contact residues and by cell specific expression at the fetal-maternal interface. PLoS One 2010, 5:e8941. 10.1371/journal.pone.0008941, 2812487, 20126612.
7. Borges L, Cosman D. LIRs/ILTs/MIRs, inhibitory and stimulatory Ig-superfamily receptors expressed in myeloid and lymphoid cells. Cytokine Growth Factor Rev 2000, 11:209-217. 10.1016/S1359-6101(00)00007-1, 10817964.
8. Hsu KC, Chida S, Geraghty DE, Dupont B. The killer cell immunoglobulin-like receptor (KIR) genomic region: gene-order, haplotypes and allelic polymorphism. Immunol Rev 2002, 190:40-52. 10.1034/j.1600-065X.2002.19004.x, 12493005.
9. Carosella ED, HoWangYin K-Y, Favier B, LeMaoult J. HLA-G-dependent suppressor cells: Diverse by nature, function, and significance. Hum Immunol 2008, 69:700-707. 10.1016/j.humimm.2008.08.280, 18817832.
10. Kapasi K, Albert SE, Yie S, Zavazava N, Librach CL. HLA-G has a concentration-dependent effect on the generation of an allo-CTL response. Immunology 2000, 101:191-200. 10.1046/j.1365-2567.2000.00109.x, 2327080, 11012772.
11. Kanai T, Fujii T, Kozuma S, Yamashita T, Miki A, Kikuchi A, Taketani Y. Soluble HLA-G influences the release of cytokines from allogeneic peripheral blood mononuclear cells in culture. Mol Hum Reprod 2001, 7:195-200. 10.1093/molehr/7.2.195, 11160846.
12. Veit TD, Vianna P, Chies JAB. HLA-G - from fetal tolerance to a regulatory molecule in inflammatory diseases. Curr Immunol Rev 2010, 6:1-15.
13. Ober C, Aldrich CL, Chervoneva I, Billstrand C, Rahimov F, Gray HL, Hyslop T. Variation in the HLA-G promoter region influences miscarriage rates. Am J Hum Genet 2003, 72:1425-1435. 10.1086/375501, 1180303, 12721954.
14. Vianna P, Dalmáz CA, Veit TD, Tedoldi C, Roisenberg I, Chies JAB. Immunogenetics of pregnancy: role of a 14-bp deletion in the maternal HLA-G gene in primiparous pre-eclamptic Brazilian women. Hum Immunol 2007, 68:668-674. 10.1016/j.humimm.2007.05.006, 17678721.
15. Gonzalez A, Alegre E, Torres MI, Díaz-Lagares A, Lorite P, Palomeque T, Arroyo A. Evaluation of HLA-G5 plasmatic levels during pregnancy and relationship with the 14-bp polymorphism. Am J Reprod Immunol 2010, 64:367-374.
16. Deschaseaux F, Delgado D, Pistoia V, Giuliani M, Morandi F, Durrbach A. HLA-G in organ transplantation: towards clinical applications. Cell Mol Life Sci 2011, 68:397-404. 10.1007/s00018-010-0581-6, 21103908.
17. Lila N, Amrein C, Guillemain R, Chevalier P, Fabiani J, Carpentier A. Soluble Human Leukocyte Antigen-G: A New Strategy for Monitoring Acute and Chronic Rejections After Heart Transplantation. J Heart Lung Transplant 2007, 26:421-422. 10.1016/j.healun.2007.01.001, 17403489.
18. Naji A, Le Rond S, Durrbach A, Krawice-Radanne I, Creput C, Daouya M, Caumartin J, LeMaoult J, Carosella ED, Rouas-Freiss N. CD3+CD4low and CD3+CD8low are induced by HLA-G: novel human peripheral blood suppressor T-cell subsets involved in transplant acceptance. Blood 2007, 110:3936-3948. 10.1182/blood-2007-04-083139, 17804694.
19. Ugurel S, Rebmann V, Ferrone S, Tilgen W, Grosse-Wilde H, Reinhold U. Soluble human leukocyte antigen-G serum level is elevated in melanoma patients and is further increased by interferon-alpha immunotherapy. Cancer 2001, 92:369-376. 10.1002/1097-0142(20010715)92:2<369::AID-CNCR1332>3.0.CO;2-U, 11466692.
20. Amiot L, Le Friec G, Sebti Y, Drénou B, Pangault C, Guilloux V, Leleu X, Bernard M, Facon T, Fauchet R. HLA-G and lymphoproliferative disorders. Semin Cancer Biol 2003, 13:379-385. 10.1016/S1044-579X(03)00029-4, 14708718.
21. Leleu X. Total Soluble HLA Class I and Soluble HLA-G in Multiple Myeloma and Monoclonal Gammopathy of Undetermined Significance. Clin Cancer Res 2005, 11:7297-7303. 10.1158/1078-0432.CCR-05-0456, 16243800.
22. Gros F, Sebti Y, de Guibert S, Branger B, Bernard M, Fauchet R, Amiot L. Soluble HLA-G molecules increase during acute leukemia, especially in subtypes affecting monocytic and lymphoid lineages. Neoplasia 2006, 8:223-230. 10.1593/neo.05703, 1578523, 16611416.
23. Ye S-R, Yang H, Li K, Dong D-D, Lin X-M, Yie S-M. Human leukocyte antigen G expression: as a significant prognostic indicator for patients with colorectal cancer. Mod Pathol 2007, 20:375-383. 10.1038/modpathol.3800751, 17277760.
24. Schütt P, Schütt B, Switala M, Bauer S, Stamatis G, Opalka B, Eberhardt W, Schuler M, Horn P, Rebmann V. Prognostic relevance of soluble human leukocyte antigen-G and total human leukocyte antigen class I molecules in lung cancer patients. Hum Immunol 2010, 71:489-495. 10.1016/j.humimm.2010.02.015, 20156510.
25. Matte C, Lajoie J, Lacaille J, Zijenah LS, Ward BJ, Roger M. Functionally active HLA-G polymorphisms are associated with the risk of heterosexual HIV-1 infection in African women. Aids 2004, 18:427-431. 10.1097/00002030-200402200-00008, 15090794.
26. Aikhionbare FO, Kumaresan K, Shamsa F, Bond VC. HLA-G DNA sequence variants and risk of perinatal HIV-1 transmission. AIDS Res Ther 2006, 3:28. 10.1186/1742-6405-3-28, 1634865, 17059603.
27. Lajoie J, Hargrove J, Zijenah LS, Humphrey JH, Ward BJ, Roger M. Genetic variants in nonclassical major histocompatibility complex class I human leukocyte antigen (HLA)-E and HLA-G molecules are associated with susceptibility to heterosexual acquisition of HIV-1. J Infect Dis 2006, 193:298-301. 10.1086/498877, 16362895.
28. Cordero EAA, Veit TD, da Silva MAL, Callegari-Jacques SM, Silla LMDR, Chies JAB. HLA-G polymorphism influences the susceptibility to HCV infection in sickle cell disease patients. Tissue Antigens 2009, 74:308-313. 10.1111/j.1399-0039.2009.01331.x, 19775370.
29. Fabris A, Catamo E, Segat L, Morgutti M, Arraes LC, de Lima-Filho JL, Crovella S. Association between HLA-G 3'UTR 14-bp polymorphism and HIV vertical transmission in Brazilian children. AIDS 2009, 23:177-182. 10.1097/QAD.0b013e32832027bf, 19098486.
30. Chen H-X, Chen B-G, Shi W-W, Zhen R, Xu D-P, Lin A, Yan W-H. Induction of cell surface human leukocyte antigen-G expression in pandemic H1N1 2009 and seasonal H1N1 influenza virus-infected patients. Hum Immunol 2011, 72:159-165. 10.1016/j.humimm.2010.11.009, 21087648.
31. Yan W-H, Lin A, Chen B-G, Chen S-Y. Induction of both membrane-bound and soluble HLA-G expression in active human cytomegalovirus infection. J Infect Dis 2009, 200:820-826. 10.1086/604733, 19619059.
32. Souto FJD, Crispim JCO, Ferreira SC, da Silva ASM, Bassi CL, Soares CP, Zucoloto S, Rouas-Freiss N, Moreau P, Martinelli AL, Donadi EA. Liver HLA-G expression is associated with multiple clinical and histopathological forms of chronic hepatitis B virus infection. J Viral Hepat 2011, 18:102-105. 10.1111/j.1365-2893.2010.01286.x, 20236238.
33. Gazit E, Slomov Y, Goldberg I, Brenner S, Loewenthal R. HLA-G is associated with pemphigus vulgaris in jewish patients. Hum Immunol 2004, 65:39-46. 10.1016/j.humimm.2003.09.019, 14700594.
34. Nicolae D, Cox NJ, Lester LA, Schneider D, Tan Z, Billstrand C, Kuldanek S, Donfack J, Kogut P, Patel NM, Goodenbour J, Howard T, Wolf R, Koppelman GH, White SR, Parry R, Postma DS, Meyers D, Bleecker ER, Hunt JS, Solway J, Ober C. Fine mapping and positional candidate studies identify HLA-G as an asthma susceptibility gene on chromosome 6p21. Am J Hum Genet 2005, 76:349-357. 10.1086/427763, 1196380, 15611928.
35. Mitsdoerffer M, Schreiner B, Kieseier BC, Neuhaus O, Dichgans J, Hartung H-P, Weller M, Wiendl H. Monocyte-derived HLA-G acts as a strong inhibitor of autologous CD4 T cell activation and is upregulated by interferon-beta in vitro and in vivo: rationale for the therapy of multiple sclerosis. J Neuroimmunol 2005, 159:155-164. 10.1016/j.jneuroim.2004.09.016, 15652415.
36. Verbruggen L, Rebmann V, Demanet C, De Cock S, Grosse-Wilde H. Soluble HLA-G in rheumatoid arthritis. Hum Immunol 2006, 67:561-567. 10.1016/j.humimm.2006.03.023, 16916651.
37. Rizzo R, Hviid TV, Govoni M, Padovan M, Rubini M, Melchiorri L, Stignani M, Carturan S, Grappa MT, Fotinidi M, Ferretti S, Voss A, Laustrup H, Junker P, Trotta F, Baricordi OR. HLA-G genotype and HLA-G expression in systemic lupus erythematosus: HLA-G as a putative susceptibility gene in systemic lupus erythematosus. Tissue antigens 2008, 71:520-529. 10.1111/j.1399-0039.2008.01037.x, 18380776.
38. Torres MI, López-Casado MA, Luque J, Peña J, Ríos A. New advances in coeliac disease: serum and intestinal expression of HLA-G. Int Immunol 2006, 18:713-718.
39. Glas J, Török HP, Tonenchi L, Wetzke M, Beynon V, Teshome MY, Cotofana S, Schiemann U, Griga T, Klein W, Epplen JT, Folwaczny C, Folwaczny M, Mussack T, Weiss EH. The 14-bp deletion polymorphism in the HLA-G gene displays significant differences between ulcerative colitis and Crohn's disease and is associated with ileocecal resection in Crohn's disease. Int Immunol 2007, 19:621-626. 10.1093/intimm/dxm027, 17446213.
40. Park KS, Park JS, Nam JH, Bang D, Sohn S, Lee ES. HLA-E*0101 and HLA-G*010101 reduce the risk of Behcet's disease. Tissue Antigens 2007, 69:139-144. 10.1111/j.1399-0039.2006.00742.x, 17257316.
41. Lin A, Yan WH, Xu HH, Tang LJ, Chen XF, Zhu M, Zhou MY. 14 bp deletion polymorphism in the HLA-G gene is a risk factor for idiopathic dilated cardiomyopathy in a Chinese Han population. Tissue Antigens 2007, 70:427-431. 10.1111/j.1399-0039.2007.00926.x, 17854427.
42. Rosado S, Perez-Chacon G, Mellor-Pita S, Sanchez-Vegazo I, Bellas-Menendez C, Citores MJ, Losada-Fernandez I, Martin-Donaire T, Rebolleda N, Perez-Aciego P. Expression of human leukocyte antigen-G in systemic lupus erythematosus. Hum Immunol 2008, 69:9-15. 10.1016/j.humimm.2007.11.001, 18295670.
43. Veit TD, Cordero EAA, Mucenic T, Monticielo OA, Brenol JCT, Xavier RM, Delgado-Cañedo A, Chies JAB. Association of the HLA-G 14 bp polymorphism with systemic lupus erythematosus. Lupus 2009, 18:424-430. 10.1177/0961203308098187, 19318395.
44. Ciprandi G, Contini P, Murdaca G, DeAmici M, Gallina AM, Puppo F. Soluble serum HLA-G and HLA-A, -B, -C molecules in patients with seasonal allergic rhinitis exposed to pollens. Int Immunopharmacol 2009, 9:1058-1062. 10.1016/j.intimp.2009.04.014, 19410660.
45. Wastowski IJ, Sampaio-Barros PD, Amstalden EMI, Palomino GM, Marques-Neto JF, Crispim JCO, Biral AC, Rassi DM, Carosella ED, Moreau P, Donadi EA. HLA-G expression in the skin of patients with systemic sclerosis. J Rheumatol 2009, 36:1230-1234. 10.3899/jrheum.080552, 19369464.
46. Forrest CM, Mackay GM, Stoy N, Spiden SL, Taylor R, Stone TW, Darlington LG. Blood levels of kynurenines, interleukin-23 and soluble human leucocyte antigen-G at different stages of Huntington's disease. J Neurochem 2010, 112:112-122. 10.1111/j.1471-4159.2009.06442.x, 19845828.
47. Cardili RN, Alves TG, Freitas JCOC, Soares CP, Mendes-Junior CT, Soares EG, Donadi EA, Silva-Souza C. Expression of human leucocyte antigen-G primarily targets affected skin of patients with psoriasis. Br J Dermatol 2010, 163:769-775. 10.1111/j.1365-2133.2010.09917.x, 20560954.
48. Fainardi E, Rizzo R, Lupato A, Ramponi V, Santis GD, Garofano F, Stignani M, Tamborino C, Castellazzi M, Casetta I, Baricordi OR. Timing of serum soluble HLA-G levels in acute and subacute phases after spontaneous intracerebral hemorrhage. Acta Neurochir Suppl 2010, 106:141-145. 10.1007/978-3-211-98811-4_25, 19812937.
49. Monneret G, Voirin N, Krawice-Radanne I, Bohé J, Lepape A, Rouas-Freiss N, Carosella ED. Soluble human leukocyte antigen-G5 in septic shock: marked and persisting elevation as a predictor of survival. Crit Care Med 2007, 35:1942-1947. 10.1097/01.CCM.0000277039.84372.1C, 17581490.
50. Geraghty DE, Koller BH, Orr HT. A human major histocompatibility complex class I gene that encodes a protein with a shortened cytoplasmic segment. Proc Natl Acad Sci USA 1987, 84:9145-9149. 10.1073/pnas.84.24.9145, 299709, 3480534.
51. HLA-G major histocompatibility complex, class I, G [Homo sapiens]. , http://www.ncbi.nlm.nih.gov/gene/3135
52. Tan Z, Randall G, Fan J, Camoretti-Mercado B, Brockman-Schneider R, Pan L, Solway J, Gern JE, Lemanske RF, Nicolae D, Ober C. Allele-specific targeting of microRNAs to HLA-G and risk of asthma. Am J Hum Genet 2007, 81:829-834. 10.1086/521200, 2227932, 17847008.
53. Castelli EC, Moreau P, Oya e Chiromatzo A, Mendes-Junior CT, Veiga-Castelli LC, Yaghi L, Giuliatti S, Carosella ED, Donadi EA. In silico analysis of microRNAS targeting the HLA-G 3' untranslated region alleles and haplotypes. Hum Immunol 2009, 70:1020-1025. 10.1016/j.humimm.2009.07.028, 19664672.
54. Rousseau P, Le Discorde M, Mouillot G, Marcou C, Carosella ED, Moreau P. The 14 pb deletion-insertion polymorphism in the 3'UTR region on the HLA-G gene influences HLA-G mRNA stability. Hum Immunol 2003, 64:1005-1010. 10.1016/j.humimm.2003.08.347, 14602228.
55. Tan Z, Shon AM, Ober C. Evidence of balancing selection at the HLA-G promoter region. Hum Mol Genet 2005, 14:3619-3628. 10.1093/hmg/ddi389, 16236759.
56. Yie S-M, Li L-H, Xiao R, Librach CL. A single base-pair mutation in the 3'-untranslated region of HLA-G mRNA is associated with pre-eclampsia. Mol Hum Reprod 2008, 14:649-653. 10.1093/molehr/gan059, 18952696.
57. Hviid TVF, Hylenius S, Rørbye C, Nielsen LG. HLA-G allelic variants are associated with differences in the HLA-G mRNA isoform profile and HLA-G mRNA levels. Immunogenetics 2003, 55:63-79.
58. Hviid TVF, Rizzo R, Christiansen OB, Melchiorri L, Lindhard A, Baricordi OR. HLA-G and IL-10 in serum in relation to HLA-G genotype and polymorphisms. Immunogenetics 2004, 56:135-141.
59. Rizzo R, Hviid TVF, Stignani M, Balboni A, Grappa MT, Melchiorri L, Baricordi OR. The HLA-G genotype is associated with IL-10 levels in activated PBMCs. Immunogenetics 2005, 57:172-181. 10.1007/s00251-005-0788-0, 15900488.
60. Rizzo R, Rubini M, Govoni M, Padovan M, Melchiorri L, Stignani M, Carturan S, Ferretti S, Trotta F, Baricordi OR. HLA-G 14-bp polymorphism regulates the methotrexate response in rheumatoid arthritis. Pharmacogenet Genomics 2006, 16:615-623. 10.1097/01.fpc.0000230115.41828.3a, 16906016.
61. Castelli EC, Mendes-Junior CT, Deghaide NHS, de Albuquerque RS, Muniz YCN, Simões RT, Carosella ED, Moreau P, Donadi EA. The genetic structure of 3'untranslated region of the HLA-G gene: polymorphisms and haplotypes. Genes Immun 2010, 11:134-141. 10.1038/gene.2009.74, 19798077.
62. Bone R, Balk R, Cerra F, Dellinger R, Fein A, Knaus W, Schein R, Sibbald W. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992, 101:1644-1655. 10.1378/chest.101.6.1644, 1303622.
63. Lahiri DK, Nurnberger JI. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res 1991, 19:5444. 10.1093/nar/19.19.5444, 328920, 1681511.
64. Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001, 68:978-989. 10.1086/319501, 1275651, 11254454.
65. Stephens M, Scheet P. Accounting for decay of linkage disequilibrium in haplotype inference and missing-data imputation. Am J Hum Genet 2005, 76:449-462. 10.1086/428594, 1196397, 15700229.
66. Excoffier L, Lischer HEL. Arlequin suite ver 3.5: a new series of programs to perform population genetics analyses under Linux and Windows. Mol Ecol Resour 2010, 10:564-567. 10.1111/j.1755-0998.2010.02847.x, 21565059.
67. Castelli EC, Mendes-Junior CT, Veiga-Castelli LC, Roger M, Moreau P, Donadi EA. A Comprehensive Study of Polymorphic Sites along the HLA-G Gene: Implication for Gene Regulation and Evolution. Mol Biol Evol 2011, 28:3069-2086. 10.1093/molbev/msr138, 21622995.
68. Lucena-Silva N, Monteiro AR, de Albuquerque RS, Gomes RG, Mendes-Junior CT, Castelli EC, Donadi EA. Haplotype frequencies based on eight polymorphic sites at the 3' untranslated region of the HLA-G gene in individuals from two different geographical regions of Brazil. Tissue Antigens 2012, 79:272-278. 10.1111/j.1399-0039.2012.01842.x, 22283419.
69. Pena SD, Di Pietro G, Fuchshuber-Moraes M, Genro JP, Hutz MH, Kehdy Fde S, Kohlrausch F, Magno LA, Montenegro RC, Moraes MO, de Moraes ME, de Moraes MR, Ojopi EB, Perini JA, Racciopi C, Ribeiro-Dos-Santos AK, Rios-Santos F, Romano-Silva MA, Sortica VA, Suarez-Kurtz G. The genomic ancestry of individuals from different geographical regions of Brazil is more uniform than expected. PloS One 2011, 6:e17063. 10.1371/journal.pone.0017063, 3040205, 21359226.